Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abbott India ropes in Rohit Gupta as Sales Director

Ruchika Sharma11 Nov 2025 1:30 PM IST

Abbott India has appointed Rohit Gupta as Sales Director."I’m happy to share that I’m starting a new position as Sales Director at Abbott," Gupta...

Granules Life Sciences gets USFDA approval for Hyderabad Facility

Ruchika Sharma11 Nov 2025 12:35 PM IST

Hyderabad: Granules India Limited has announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), located in...

Telangana issues advisory on prescription medicines sales in Telangana

Zydus gets China NMPA nod for Major Depressive Disorder drug Venlafaxine ER

Ruchika Sharma11 Nov 2025 11:47 AM IST

Ahmedabad: Zydus Lifesciences Limited has received nod from the National Medical Products Administration (NMPA), China for Venlafaxine...

Novartis opens new radioligand therapy manufacturing facility in California

Ruchika Sharma11 Nov 2025 10:30 AM IST

Basel: Novartis, a global medicines company, has announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in...

Cohance Lifesciences appoints Rahul Pradhan as VP - Operations to head API Unit III, Ankleshwar

Ruchika Sharma10 Nov 2025 4:44 PM IST

Cohance Lifesciences has announced the appointment of Rahul Pradhan as Vice President - Operations to head API Unit III, Ankleshwar.A seasoned...

Cough Syrup Row: Rajasthan Practitioners Shift to Levocloperastine, Ambroxol Amid Dextromethorphan Concerns

DEG impurity above limit found in another cough syrup, Haryana issues alert

Ruchika Sharma10 Nov 2025 4:00 PM IST

Haryana: Barely weeks after the ColdRif - linked child deaths in Madhya Pradesh shocked the nation, Haryana has issued a public health alert over...

Dr Sujiv Nair takes over as Chief People Officer of MSN Group

Ruchika Sharma10 Nov 2025 3:30 PM IST

MSN Labs has announced the appointment of Dr Sujiv Nair as Chief People Officer - MSN Group.Dr Sujiv brings over three decades of global experience...

Intas Pharma ropes in Sujit Mandal as Associate Vice President - Manufacturing Finance

Ruchika Sharma10 Nov 2025 2:30 PM IST

Ahmedabad: Intas Pharma has announced the appointment of Sujit Mandal as Associate Vice President – Manufacturing Finance.Sujit brings rich...

Lupin gets seven USFDA observations for Goa facility

USFDA concludes inspection at Marksans Pharma Goa facility with zero Form 483 observation

Ruchika Sharma10 Nov 2025 12:34 PM IST

Mumbai: Marksans Pharma has announced that the U.S. Food and Drug Administration (USFDA) has concluded an inspection at the 2nd manufacturing facility...

Merck Receives Positive EU CHMP Opinion for Expanded Use of Winrevair in Adults with Pulmonary Arterial Hypertension

Merck inks pact with Dr Falk Pharma for certain development, commercialization rights to MK 8690

Ruchika Sharma10 Nov 2025 11:15 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the company, through a subsidiary Prometheus BioSciences, has...

Biocon to make Biocon Biologics a wholly owned arm

Biocon gets 2 USFDA observations for Visakhapatnam facility

Ruchika Sharma9 Nov 2025 5:00 PM IST

Biocon has announced that the U.S. Food and Drug Administration (US FDA) has concluded an inspection with two observations at its API facility...

CDSCO Panel Directs Mankind Pharma to Conduct Phase I Trial of Sintilimab Before Phase III Launch

Mankind Pharma net profit declines 21 percent to Rs 520 crore in Q2

Ruchika Sharma9 Nov 2025 4:00 PM IST

Mankind Pharma Ltd has posted a 21 percent year-on-year decline in its consolidated profit after tax (PAT) to Rs 520 crore for the quarter ended...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok